124 related articles for article (PubMed ID: 37684411)
1. Correction: Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis.
Richards JR; Shin D; Pryor R; Sorensen LK; Sun Z; So WM; Park G; Wolff R; Truong A; McMahon M; Grossmann AH; Harbour JW; Zhu W; Odelberg SJ; Yoo JH
Oncogene; 2023 Sep; 42(40):3015. PubMed ID: 37684411
[No Abstract] [Full Text] [Related]
2. Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis.
Richards JR; Shin D; Pryor R; Sorensen LK; Sun Z; So WM; Park G; Wolff R; Truong A; McMahon M; Grossmann AH; Harbour JW; Zhu W; Odelberg SJ; Yoo JH
Oncogene; 2023 Aug; 42(35):2629-2640. PubMed ID: 37500798
[TBL] [Abstract][Full Text] [Related]
3. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
[TBL] [Abstract][Full Text] [Related]
4. The Role of HGF/MET Signaling in Metastatic Uveal Melanoma.
Tanaka R; Terai M; Londin E; Sato T
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771620
[TBL] [Abstract][Full Text] [Related]
5. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():20-5. PubMed ID: 19032678
[TBL] [Abstract][Full Text] [Related]
6. Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma.
Cheng H; Chua V; Liao C; Purwin TJ; Terai M; Kageyama K; Davies MA; Sato T; Aplin AE
Mol Cancer Ther; 2017 Mar; 16(3):516-528. PubMed ID: 28138035
[TBL] [Abstract][Full Text] [Related]
7. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4372-5. PubMed ID: 16303922
[TBL] [Abstract][Full Text] [Related]
8. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
9. Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma
Musi E; Schwartz GK; Yoo JH; Odelberg SJ; Li DY; Bonner MY; Selvakumar P; Rao S; Gilbert LC; Elsey J; Arbiser JL
Oncotarget; 2019 Jul; 10(43):4424-4436. PubMed ID: 31320995
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth.
Yoshida M; Selvan S; McCue PA; DeAngelis T; Baserga R; Fujii A; Rui H; Mastrangelo MJ; Sato T
Pigment Cell Melanoma Res; 2014 Mar; 27(2):297-308. PubMed ID: 24354797
[TBL] [Abstract][Full Text] [Related]
11. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
[TBL] [Abstract][Full Text] [Related]
12. Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.
Cheng H; Terai M; Kageyama K; Ozaki S; McCue PA; Sato T; Aplin AE
Cancer Res; 2015 Jul; 75(13):2737-48. PubMed ID: 25952648
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanoma and macular degeneration: molecular biology and potential therapeutic applications.
Economou MA
Acta Ophthalmol; 2008 Dec; 86(8):930-1. PubMed ID: 19086934
[TBL] [Abstract][Full Text] [Related]
14. PHA665752 inhibits the HGF-stimulated migration and invasion of cells by blocking PI3K/AKT pathway in uveal melanoma.
Wang Z; He C; Liu L; Ma N; Chen X; Zheng D; Qiu GH
Neoplasma; 2017; 64(3):377-388. PubMed ID: 28253717
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological significance of expression of IGF-1R in uveal melanoma and its association with expression of p-AKT Thr308].
Bao XL; Song H; Tang X
Zhonghua Yan Ke Za Zhi; 2012 May; 48(5):413-6. PubMed ID: 22932330
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
[TBL] [Abstract][Full Text] [Related]
17. Secretion of hepatocyte growth factor and vascular endothelial growth factor during uveal melanoma-monocyte in vitro interactions.
Cools-Lartigue J; Marshall JC; Caissie AL; Saraiva VS; Burnier MN
Melanoma Res; 2005 Jun; 15(3):141-5. PubMed ID: 15917694
[TBL] [Abstract][Full Text] [Related]
18. Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis.
Hongu T; Yamauchi Y; Funakoshi Y; Katagiri N; Ohbayashi N; Kanaho Y
Small GTPases; 2016 Apr; 7(2):47-53. PubMed ID: 26909552
[TBL] [Abstract][Full Text] [Related]
19. Arf GTPase-activating protein ASAP1 interacts with Rab11 effector FIP3 and regulates pericentrosomal localization of transferrin receptor-positive recycling endosome.
Inoue H; Ha VL; Prekeris R; Randazzo PA
Mol Biol Cell; 2008 Oct; 19(10):4224-37. PubMed ID: 18685082
[TBL] [Abstract][Full Text] [Related]
20. The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.
Yoo JH; Brady SW; Acosta-Alvarez L; Rogers A; Peng J; Sorensen LK; Wolff RK; Mleynek T; Shin D; Rich CP; Kircher DA; Bild A; Odelberg SJ; Li DY; Holmen SL; Grossmann AH
Cancer Res; 2019 Jun; 79(11):2892-2908. PubMed ID: 31048499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
